We are closed on November 23rd and November 24th in observance of Thanksgiving. View More Important Notifications x
texas oncology more breakthroughs. more victories
  • Request an Appointment
  • Find a cancer center
  • Find a provider
  • Clinical Trials

Share:

 
 

Helen Dinkelspiel Eshed, M.D.

General Summary

Dr. Helen Dinkelspiel Eshed is board certified in obstetrics and gynecology and gynecologic oncology.

Education

  • Fellowship in Gynecologic Oncology
    Columbia University College of Physicians and Surgeons, Weill Cornell Medical College, New York, NY
  • Residency in Obstetrics and Gynecology
    University of California Davis, Sacramento, CA
  • Medical Doctorate
    Albany Medical College, Albany, NY
  • Bachelor of Arts
    Dartmouth College, Hanover, NH

Medical Practice

Other Information

Originally from Tennessee, Dr. Helen Dinkelspiel Eshed graduated with a Bachelor of Arts from Dartmouth College. She received her medical degree from Albany Medical College before completing residency training in Obstetrics and Gynecology at the University of California Davis. She then completed fellowship training in Gynecologic Oncology at Columbia University College of Physicians and Surgeons and Weill Cornell Medical College in New York, NY.

In addition to her clinical, academic, and research pursuits, Dr. Eshed has competed in many Ironman, marathons, and triathlons, including the USAT Olympic National Championships and Ironman 70.3 World Championships.

Accolades & Memberships

  • American Congress of Obstetrics and Gynecology
  • Society of Gynecologic Oncology
  • Conquer Cancer Foundation of American Society of Clinical Oncology (ASCO) Young Investigator Award grant recipient, 2015

Community Service

Research Interest

Dr. Eshed specializes in the care of women with gynecologic cancers including cervical, uterine or endometrial, ovarian, vulvar, and vaginal cancers. Dr. Eshed has extensive experience in minimally invasive surgery including laparoscopic and Da Vinci robotic surgery, complex pelvic surgery, and radical cytoreductive surgery for advanced cancers, as well as chemotherapeutic and novel biologic treatments for gynecologic cancers.

She is actively involved in clinical trials to individualize patient care and improve patients’ outcomes and quality of life. She has authored over a dozen peer-reviewed publications and presents lectures nationally and internationally on research in gynecologic cancers. She was the recipient of the American Society of Clinical Oncology (ASCO) Young Investigator Award grant for her research efforts in minimally invasive gynecologic cancer surgery.

Dr. Eshed is the principal investigator in USOR 17052 using an anti-PD1 monoclonal antibody REGN2810 vs. investigator’s choice chemotherapy for metastatic or recurrent platinum resistant cervical cancer.

Publications

  • Feasibility and Learning Curve of Robotic Laparo-Endoscopic Single Site Surgery in Gynecology

    Journal of Minimally Invasive Gynecology, 2017

  • A case of mesothelioma masquerading pre-operatively as ovarian cancer and brief review of the literature

    Gynecologic Oncology Reports, 2016

  • Does the presence of endometriosis affect prognosis in ovarian cancer?

    Cancer Invest, 2016

  • Sclerosing mesenteritis mimics gynecologic malignancy

    Gynecologic Oncology Reports, 2015

  • Long-term mortality among women with epithelial ovarian cancer

    Gynecologic Oncology, 2015

Show all Publications
  • Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer

    Gynecologic Oncology, 2015

  • Increased cervical cancer risk associated with screening at longer intervals

    Obstetrics & Gynecology, 2015

  • State of the Science: Cervical cancer screening in transition

    Gynecologic Oncology, 2014

  • New Mexico HPV Pap Registry Steering Committee. Cervical excisional treatment of young women: a population-based study

    Gynecologic Oncology, 2014

  • Minimally invasive vs. open pancreaticoduodenectomy: systematic review and meta-analysis

    Journal of the American College of Surgeons, 2014

  • The presence of endometriosis is associated with improved survival in epithelial ovarian cancer.

    Poster presentation at the Society for Gynecologic Oncology 45th Annual Meeting on Women’s Cancer, 2014

  • Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer.

    Poster presentation at the Society for Gynecologic Oncology 45th Annual Meeting on Women’s Cancer, 2014

  • Long-term mortality among women with epithelial ovarian cancer.

    Poster presentation at the New York Obstetrics Society Meeting, 2014

  • Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer.

    Poster presentation at the New York Obstetrics Society Meeting, 2013

  • Cervical cancer rates after the transition from annual Pap to 3-year HPV and Pap

    Journal of Lower Genital Tract Disease, 2013

  • Contemporary clinical management of endometrial cancer

    Obstetrics and Gynecology International, 2013

  • Fallopian tube removal: "stic-ing" it to ovarian cancer: what is the utility of prophylactic tubal removal?

    Current Oncology, 2013

  • ​Identification of master regulators of platinum resistance in ovarian cancer.

    Oral Plenary presentation at the Society for Gynecologic Oncology 44th Annual Meeting on Women’s Cancer, 2013

  • Fallopian tube origin of ovarian cancer: salpingectomy in benign gynecologic surgery.

    Oral presentation at Columbia University College of Physicians and Surgeons Grand Rounds, 2013

  • Screening history preceding a diagnosis of cervical cancer in women age 65 and older

    Gynecologic Oncology, 2012

  • Screening history preceding and long-term risk of invasive cervical cancer following diagnosis of adenocarcinoma in situ in routine clinical practice.

    Poster presentation at the Society for Gynecologic Oncology 43rd Annual Meeting on Women’s Cancer, 2012

  • Sustained rise in the diagnosis of adenocarcinoma in situ in routine clinical practice.

    Poster presentation at the American Society of Colposcopists and Cervical Pathologists Biennial Scientific Meeting, 2012

  • Lessons from practice: cervical cancer antecedents in the cotesting era.

    Oral presentation at the Western Association of Gynecologic Oncologists 40th Annual Meeting, 2011

  • Screening history preceding a diagnosis of cervical cancer in women age 65 and older. 

    Oral presentation at Eurogin Conference, 2011

  • Risk of invasive cancer in routine clinical practice following a CIN2 or CIN2/3 biopsy.

    Oral presentation at Eurogin Conference, 2011

  • Cervical cancer rates in clinical practice with cotesting and interval extension.

    Oral Plenary presentation at the Society for Gynecologic Oncology 42nd Annual Meeting on Women’s Cancer, 2011

  • Pap negative HPV positive screening results: compliance with follow-up and results of follow-up.

    Featured Poster presentation at the Society for Gynecologic Oncology 42nd Annual Meeting on Women’s Cancer, 2011

  • Consequences of lengthening cervical cancer screening intervals on mammography rates.

    Poster presentation at the Society for Gynecologic Oncology 42nd Annual Meeting on Women’s Cancer, Orlando, 2011